Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 24 articles: HTML format

Single Articles

October 2025
1. KALRA A, Ma K, Cheng Y, Tsai HL, et al
   Discovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
   Am J Gastroenterol. 2025;120:2268-2279.
   PubMed     Abstract available
   
   
   August 2025
2. SHAH T, Ansari Z, Ahmad A, Coyle W, et al
   Spray Cryotherapy Esophageal Consortium (SPEC) Consensus Recommendations for Liquid Nitrogen Spray Cryotherapy in Barrett's Esophagus and Esophageal Cancer using a Modified Delphi Process.
   Am J Gastroenterol. 2025 Aug 26. doi: 10.14309/ajg.0000000000003752.
   PubMed     Abstract available
   
   
   April 2025
3. JACOBSON DH, Fitzgerald RC
   Barrett's Esophagus in Time and Space: A Methylation Panel for Tracking Esophageal Cancer.
   Am J Gastroenterol. 2025 Apr 7. doi: 10.14309/ajg.0000000000003378.
   PubMed    
   
   
   
4. LIANG J, Rastegar R, El Helou M, Mathur K, et al
   Incidence Trends in Upper Gastrointestinal Cancer in Young Adults: A Nationwide Time-Trend Analysis Using 2001-2019 US Cancer Statistics Databases.
   Am J Gastroenterol. 2025;120:890-904.
   PubMed     Abstract available
   
   
   March 2025
5. GREER KB, Blum AE, Faulx AL, Deming EM, et al
   Nonendoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma in At-Risk Veterans.
   Am J Gastroenterol. 2025;120:545-553.
   PubMed     Abstract available
   
   
   February 2025
6. LAUN SE, Kann L, Braun J, Pierre F, et al
   Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus.
   Am J Gastroenterol. 2025;120:1285-1295.
   PubMed     Abstract available
   
   
   November 2024
7. SHAHEEN NJ, Othman MO, Taunk J, Chang KJ, et al
   Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population.
   Am J Gastroenterol. 2024;120:1511-1520.
   PubMed     Abstract available
   
   
   
8. HUANG Y, Huang H, Wei T, Zhang A, et al
   Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the United States.
   Am J Gastroenterol. 2024;120:1367-1380.
   PubMed     Abstract available
   
   
   
9. MOINOVA HR, Verma S, Dumot J, Faulx A, et al
   Multicenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
   Am J Gastroenterol. 2024;119:2206-2214.
   PubMed     Abstract available
   
   
   October 2024
10. SHAHEEN NJ, Odze RD, Singer ME, Salyers WJ, et al
    Adjunctive Use of Wide-Area Transepithelial Sampling-3D in Patients With Symptomatic Gastroesophageal Reflux Increases Detection of Barrett's Esophagus and Dysplasia.
    Am J Gastroenterol. 2024;119:1990-2001.
    PubMed     Abstract available
    
    
    September 2024
11. SIJBEN J, Rainey L, Maas F, Broeders MJM, et al
    The Public's Intended Uptake of Hypothetical Esophageal Adenocarcinoma Screening Scenarios: A Nationwide Survey.
    Am J Gastroenterol. 2024;119:1802-1812.
    PubMed     Abstract available
    
    
    
12. VANTANASIRI K, Joseph A, Sachdeva K, Goyal R, et al
    Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett's Neoplasia by Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection and Ablation: A Large North American Multicenter Cohort.
    Am J Gastroenterol. 2024;119:1831-1840.
    PubMed     Abstract available
    
    
    August 2024
13. POMENTI SF, Flashner SP, Del Portillo A, Nakagawa H, et al
    Clinical and biological perspectives on non-canonical esophageal squamous cell carcinoma in rare subtypes.
    Am J Gastroenterol. 2024 Aug 21. doi: 10.14309/ajg.0000000000003041.
    PubMed     Abstract available
    
    
    
14. LAUN SE, Kann L, Braun J, Gilbert S, et al
    Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus.
    Am J Gastroenterol. 2024;120:1296-1306.
    PubMed     Abstract available
    
    
    July 2024
15. YOON JY, Lim F, Shah SC, Rubenstein JH, et al
    Endoscopic Surveillance of Intestinal Metaplasia of the Esophagogastric Junction: A Decision Modeling Analysis.
    Am J Gastroenterol. 2024;119:1289-1297.
    PubMed     Abstract available
    
    
    May 2024
16. KADOTA T, Abe S, Uedo N, Doyama H, et al
    Comparison of effective imaging modalities for detecting gastric neoplasms: A randomized three-arm phase II trial.
    Am J Gastroenterol. 2024 May 16. doi: 10.14309/ajg.0000000000002871.
    PubMed     Abstract available
    
    
    
17. CHANDAR AK, Keerthy K, Gupta R, Grady WM, et al
    Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
    Am J Gastroenterol. 2024;119:823-829.
    PubMed     Abstract available
    
    
    April 2024
18. KAMBOJ AK, Goyal R, Vantanasiri K, Sachdeva K, et al
    Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
    Am J Gastroenterol. 2024;119:662-670.
    PubMed     Abstract available
    
    
    February 2024
19. POKALA SK, Williams JL, Holub JL, Calderwood AH, et al
    Significant Reduction in the Diagnosis of Barrett's Esophagus and Related Dysplasia During the COVID-19 Pandemic.
    Am J Gastroenterol. 2024;119:251-261.
    PubMed     Abstract available
    
    
    December 2023
20. JIANG H, Chen R, Li Y, Hao C, et al
    Performance of prediction models for esophageal squamous cell carcinoma in general population: a systematic review and external validation study.
    Am J Gastroenterol. 2023 Dec 13. doi: 10.14309/ajg.0000000000002629.
    PubMed     Abstract available
    
    
    November 2023
21. LOW EE, Demb J, Shah SC, Liu L, et al
    Risk of Esophageal Cancer in Achalasia: A Matched Cohort Study Utilizing the Nationwide Veterans Affairs Achalasia Cohort (VA-AC).
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002591.
    PubMed     Abstract available
    
    
    
22. NOURELDIN M, Rubenstein JH, Urias E, Berinstein JA, et al
    RACIAL DISPARITY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA TREATMENT AND SURVIVAL IN THE UNITED STATES.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002606.
    PubMed     Abstract available
    
    
    
23. DUITS LC, Khoshiwal AM, Frei NF, Pouw RE, et al
    An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus.
    Am J Gastroenterol. 2023;118:2025-2032.
    PubMed     Abstract available
    
    
    October 2023
24. JIANG H, Xin L, Wang L
    Management of Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa or Shallow Submucosal Layer After Endoscopic Resection.
    Am J Gastroenterol. 2023;118:1900.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.